Literature DB >> 23760268

Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.

Jin Xu1, Ming Xu1, Taylor Brown1, Grace C Rossi2, Yasmin L Hurd3, Charles E Inturrisi4, Gavril W Pasternak5, Ying-Xian Pan6.   

Abstract

The μ-opioid receptor gene, OPRM1, undergoes extensive alternative pre-mRNA splicing, as illustrated by the identification of an array of splice variants generated by both 5' and 3' alternative splicing. The current study reports the identification of another set of splice variants conserved across species that are generated through exon skipping or insertion that encodes proteins containing only a single transmembrane (TM) domain. Using a Tet-Off system, we demonstrated that the truncated single TM variants can dimerize with the full-length 7-TM μ-opioid receptor (MOR-1) in the endoplasmic reticulum, leading to increased expression of MOR-1 at the protein level by a chaperone-like function that minimizes endoplasmic reticulum-associated degradation. In vivo antisense studies suggested that the single TM variants play an important role in morphine analgesia, presumably through modulation of receptor expression levels. Our studies suggest the functional roles of truncated receptors in other G protein-coupled receptor families.

Entities:  

Keywords:  Alternative Splicing; Analgesia; Antisense Oligodeoxynucleotide; Dimerization; G Protein-coupled Receptors (GPCR); Molecular Chaperone; Morphine; Opiate Opioid; Receptor Regulation

Mesh:

Substances:

Year:  2013        PMID: 23760268      PMCID: PMC3774389          DOI: 10.1074/jbc.M113.458687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: evidence for region-specific processing.

Authors:  C Abbadie; Y X Pan; G W Pasternak
Journal:  J Comp Neurol       Date:  2000-04-03       Impact factor: 3.215

2.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.

Authors:  Susruta Majumdar; Joan Subrath; Valerie Le Rouzic; Lisa Polikar; Maxim Burgman; Kuni Nagakura; Julie Ocampo; Nathan Haselton; Anna R Pasternak; Steven Grinnell; Ying-Xian Pan; Gavril W Pasternak
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

Review 4.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

5.  Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS.

Authors:  C Abbadie; Y Pan; C T Drake; G W Pasternak
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.

Authors:  Susruta Majumdar; Steven Grinnell; Valerie Le Rouzic; Maxim Burgman; Lisa Polikar; Michael Ansonoff; John Pintar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

7.  Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation.

Authors:  Shao-Qiu He; Zhen-Ning Zhang; Ji-Song Guan; Hong-Rui Liu; Bo Zhao; Hai-Bo Wang; Qian Li; Hong Yang; Jie Luo; Zi-Yan Li; Qiong Wang; Ying-Jin Lu; Lan Bao; Xu Zhang
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

8.  UMB-3, a novel rabbit monoclonal antibody, for assessing μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues.

Authors:  Amelie Lupp; Nadine Richter; Christian Doll; Falko Nagel; Stefan Schulz
Journal:  Regul Pept       Date:  2010-09-17

9.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

10.  Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1.

Authors:  Jin Xu; Mingming Xu; Grace C Rossi; Gavril W Pasternak; Ying-Xian Pan
Journal:  Mol Pain       Date:  2011-01-21       Impact factor: 3.395

View more
  31 in total

1.  Splice variation of the mu-opioid receptor and its effect on the action of opioids.

Authors:  Sophy K Gretton; Joanne Droney
Journal:  Br J Pain       Date:  2014-11

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization.

Authors:  Tiffany Zhang; Jin Xu; Ying-Xian Pan
Journal:  Mol Pharmacol       Date:  2020-07-28       Impact factor: 4.436

4.  Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.

Authors:  Jin Xu; Zhigang Lu; Ankita Narayan; Valerie P Le Rouzic; Mingming Xu; Amanda Hunkele; Taylor G Brown; William F Hoefer; Grace C Rossi; Richard C Rice; Arlene Martínez-Rivera; Anjali M Rajadhyaksha; Luca Cartegni; Daniel L Bassoni; Gavril W Pasternak; Ying-Xian Pan
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

5.  A "tail" of opioid receptor variants.

Authors:  Stephanie Puig; Howard B Gutstein
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

6.  A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.

Authors:  Jin Xu; Zhigang Lu; Mingming Xu; Ling Pan; Yi Deng; Xiaohu Xie; Huifen Liu; Shixiong Ding; Yasmin L Hurd; Gavril W Pasternak; Robert J Klein; Luca Cartegni; Wenhua Zhou; Ying-Xian Pan
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

Review 7.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

Review 8.  Opiate pharmacology and relief of pain.

Authors:  Gavril W Pasternak
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

9.  Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.

Authors:  Gina F Marrone; Steven G Grinnell; Zhigang Lu; Grace C Rossi; Valerie Le Rouzic; Jin Xu; Susruta Majumdar; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

Review 10.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.